Similarly, our annexin V assay results showcased that the KRAS mutant CRC cells underwent a significantly greater degree of apoptosis when compared to the KRAS WT CRC cells, following treatment with PRMT5 inhibitor. Here, PRMT5 is linked to colorectal carcinoma.